Cargando…
Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery()
Metabolism represents the ‘sharp end’ of systems biology, because changes in metabolite concentrations are necessarily amplified relative to changes in the transcriptome, proteome and enzyme activities, which can be modulated by drugs. To understand such behaviour, we therefore need (and increasingl...
Autores principales: | Kell, Douglas B., Goodacre, Royston |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Ltd., Distributed by Virgin Mailing and Distribution
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3989035/ https://www.ncbi.nlm.nih.gov/pubmed/23892182 http://dx.doi.org/10.1016/j.drudis.2013.07.014 |
Ejemplares similares
-
Corrigendum to “Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery” [Drug Discov. Today 19 (2014), 171–182()
por: Kell, Douglas B, et al.
Publicado: (2014) -
Metabolomics shows the way to new discoveries
por: Goodacre, Royston
Publicado: (2005) -
Commentary on “Rapid identification of Streptococcus and Enterococcus species using diffuse reflectance-absorbance Fourier transform infrared spectroscopy and artificial neural networks”
por: Goodacre, Royston, et al.
Publicado: (2017) -
NEWS: the 2023 Metabolomics publication awards
por: Goodacre, Royston
Publicado: (2023) -
A novel untargeted metabolomics correlation-based network analysis incorporating human metabolic reconstructions
por: Kotze, Helen L, et al.
Publicado: (2013)